HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients.

Chiu, Connie G

HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients. [electronic resource] - Annals of surgery Jun 2010 - 1107-16 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1528-1140

10.1097/SLA.0b013e3181dbb77e doi


Adult
Aged
Breast Neoplasms--metabolism
ErbB Receptors--metabolism
Female
Humans
Middle Aged
Prognosis
Receptor, ErbB-2--metabolism
Receptor, ErbB-3--metabolism
Receptor, ErbB-4
Survival Rate
Tissue Array Analysis